ANIXA BIOSCIENCES INC Current Ratio 2010-2022 | ANIX
ANIXA BIOSCIENCES INC current ratio from 2010 to 2022. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
ANIXA BIOSCIENCES INC Current Ratio Historical Data |
Date |
Current Assets |
Current Liabilities |
Current Ratio |
2022-10-31 |
$0.03B |
$0.00B |
14.83 |
2022-07-31 |
$0.03B |
$0.00B |
22.02 |
2022-04-30 |
$0.03B |
$0.00B |
27.39 |
2022-01-31 |
$0.04B |
$0.00B |
19.58 |
2021-10-31 |
$0.04B |
$0.00B |
28.35 |
2021-07-31 |
$0.04B |
$0.00B |
30.67 |
2021-04-30 |
$0.04B |
$0.00B |
26.66 |
2021-01-31 |
$0.02B |
$0.00B |
9.55 |
2020-10-31 |
$0.01B |
$0.00B |
7.88 |
2020-07-31 |
$0.01B |
$0.00B |
7.64 |
2020-04-30 |
$0.01B |
$0.00B |
5.25 |
2020-01-31 |
$0.01B |
$0.00B |
5.21 |
2019-10-31 |
$0.01B |
$0.00B |
4.11 |
2019-07-31 |
$0.01B |
$0.00B |
4.59 |
2019-04-30 |
$0.01B |
$0.00B |
4.70 |
2019-01-31 |
$0.01B |
$0.00B |
4.70 |
2018-10-31 |
$0.01B |
$0.00B |
4.38 |
2018-07-31 |
$0.01B |
$0.00B |
5.06 |
2018-04-30 |
$0.01B |
$0.00B |
4.27 |
2018-01-31 |
$0.01B |
$0.00B |
5.32 |
2017-10-31 |
$0.01B |
$0.00B |
7.89 |
2017-07-31 |
$0.01B |
$0.00B |
2.20 |
2017-04-30 |
$0.01B |
$0.00B |
1.42 |
2017-01-31 |
$0.00B |
$0.00B |
0.56 |
2016-10-31 |
$0.00B |
$0.00B |
7.25 |
2016-07-31 |
$0.00B |
$0.00B |
7.54 |
2016-04-30 |
$0.01B |
$0.00B |
6.79 |
2016-01-31 |
$0.01B |
$0.00B |
4.97 |
2015-10-31 |
$0.01B |
$0.00B |
11.61 |
2015-07-31 |
$0.01B |
$0.00B |
10.90 |
2015-04-30 |
$0.01B |
$0.00B |
12.38 |
2015-01-31 |
$0.01B |
$0.00B |
6.34 |
2014-10-31 |
$0.01B |
$0.00B |
3.49 |
2014-07-31 |
$0.01B |
$0.01B |
0.77 |
2014-04-30 |
$0.00B |
$0.01B |
0.34 |
2014-01-31 |
$0.00B |
$0.01B |
0.29 |
2013-10-31 |
$0.00B |
$0.00B |
0.38 |
2013-07-31 |
$0.00B |
$0.00B |
0.33 |
2013-04-30 |
$0.00B |
$0.00B |
0.40 |
2013-01-31 |
$0.00B |
$0.00B |
0.52 |
2012-10-31 |
$0.00B |
$0.00B |
0.51 |
2012-07-31 |
$0.00B |
$0.00B |
0.64 |
2012-04-30 |
$0.00B |
$0.00B |
0.84 |
2012-01-31 |
$0.00B |
$0.00B |
1.27 |
2011-10-31 |
$0.00B |
$0.00B |
1.48 |
2011-07-31 |
$0.00B |
$0.00B |
1.25 |
2011-04-30 |
$0.00B |
$0.00B |
3.23 |
2011-01-31 |
$0.00B |
$0.00B |
1.87 |
2010-10-31 |
$0.00B |
$0.00B |
2.74 |
2010-07-31 |
$0.00B |
$0.00B |
3.10 |
2010-04-30 |
$0.00B |
$0.00B |
5.07 |
2010-01-31 |
$0.00B |
$0.00B |
5.43 |
2009-10-31 |
$0.00B |
$0.00B |
6.05 |
2009-07-31 |
$0.00B |
$0.00B |
10.28 |
2009-04-30 |
$0.00B |
$0.00B |
5.24 |
2009-01-31 |
$0.00B |
$0.00B |
4.16 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Biomedical and Genetics |
$0.141B |
$0.001B |
Anixa Biosciences, Inc. operates as a bio-technology company. It develops diagnostics and therapeutics to detect cancer. Anixa Biosciences Inc., formerly known as ITUS Corporation, is based in San Jose, United States.
|